MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by the hallmarks of tau and amyloid-β deposits, associated with reactive gliosis, neuronal degeneration, neurotransmitter imbalance, and glucose hypometabolism [1, 2].